In a phase 1 clinical trial, researchers have tested a new STAT3-targeted therapy in pet cats diagnosed with head and neck squamous cell carcinoma (HNSCC), a type of oral cancer that is typically ... Researchers at UCSF and UC Davis teamed up to study one of the most aggressive cancers in cats: squamous cell carcinoma. Most cats survive only two to three months after diagnosis.

Understanding the Context

Teams tested a drug ... Oral cancer is often a death sentence in cats. Sick cats excel at hiding their symptoms, so the cancer is typically diagnosed at an advanced, untreatable stage. “Most of the time these cats come in, I ...

Key Insights

FIRST CLINICAL TRIAL OF A NEW CANCER DRUG FOR CATS. AND IT COULD HAVE APPLICATIONS FOR HUMANS. YEAH, IT’S INTERESTING. SCIENTISTS AT UC DAVIS AND UC SAN FRANCISCO HAVE TREATED CATS WITH SQUAMOUS CELL ... Head and neck squamous cell carcinoma (HNSCC) is approximately the seventh most common cancer in humans with an estimated 900,000 new cases globally.

Final Thoughts

As a surgeon, Jennifer Grandis, MD, a physician ...